Aemetis (NASDAQ:AMTX) Shares Pass Below Two Hundred Day Moving Average – Time to Sell?

Shares of Aemetis, Inc (NASDAQ:AMTX) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.02 and traded as low as $1.90. Aemetis shares last traded at $1.96, with a volume of 902,854 shares trading hands.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on AMTX. Wall Street Zen lowered shares of Aemetis from a “hold” rating to a “sell” rating in a research note on Saturday, June 6th. Loop Capital set a $1.75 target price on shares of Aemetis in a research report on Thursday, March 12th. Weiss Ratings restated a “sell (e+)” rating on shares of Aemetis in a report on Monday, April 20th. Finally, Ascendiant Capital Markets upped their target price on shares of Aemetis from $21.00 to $22.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $8.92.

Aemetis Price Performance

The company has a market cap of $137.92 million, a PE ratio of -1.65 and a beta of 1.36. The company has a 50-day moving average of $2.44 and a 200-day moving average of $2.02.

Aemetis (NASDAQ:AMTX) last released its quarterly earnings results on Thursday, May 7th. The specialty chemicals company reported ($0.33) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.06). The company had revenue of $54.62 million during the quarter, compared to analyst estimates of $66.70 million. As a group, equities analysts predict that Aemetis, Inc will post -1.11 EPS for the current year.

Institutional Trading of Aemetis

Several institutional investors and hedge funds have recently made changes to their positions in the company. Royal Bank of Canada boosted its holdings in Aemetis by 10,632.5% during the first quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock worth $28,000 after purchasing an additional 8,825 shares during the last quarter. Creative Planning bought a new stake in Aemetis in the 2nd quarter worth about $30,000. Virtu Financial LLC purchased a new stake in Aemetis in the 4th quarter valued at about $31,000. Sanctuary Advisors LLC purchased a new stake in Aemetis in the 1st quarter valued at about $33,000. Finally, HRT Financial LP bought a new stake in Aemetis during the fourth quarter worth $36,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.